ZHEJIANG XIANFENG TECHNOLOGY GROUP CO.,LTD.

Zhejiang Xianfeng Technology Group Co., Ltd., headquartered in Linhai City, Taizhou, is a high-tech enterprise whose roots trace to Linhai Pioneer Chemical Co., Ltd., founded in 2002; through successive renamings, a 2012 pharmaceutical subsidiary, and acquisitions including Taizhou Wanxing Machinery Equipment in 2017 and Shanxi Green Sea Pesticide Technology in 2021, it has grown into a diversified group spanning active pharmaceutical ingredients, intermediates and fine chemicals, bio products, natural extracts, finished dosage forms, pharmaceutical excipients, and outsourced custom development and consulting services. The company holds more than twenty invention patents covering nucleoside and pyrimidine intermediate synthesis routes -- including uridine, cytosine, 5-fluorocytosine, and rivaroxaban and atorvastatin intermediates -- and offers CRO, CMO, and CDMO contract services with roughly 65% of output exported. Guided by a culture of innovation, flexibility, and teamwork, the company ships to customers across North America, Latin America, Europe, Australasia, Asia, the Middle East, and Africa.